Dexid-400

Indications

• Nitrogen supplementation in clinical nutrition
• Management of metabolic alkalosis
• Treatment of certain types of kidney disorders

Dosage

Children: Specific pediatric dosing information is not detailed in the BNF. Refer to the BNF for Children for appropriate dosing based on age and condition.

Adults: Dosage varies based on clinical indication and should be guided by specific treatment protocols. Refer to clinical guidelines for detailed dosing information.

Mechanism of action

Ammonium ions participate in various metabolic pathways, including the biosynthesis of amino acids and nucleotides. It serves as a nitrogen source for organisms, facilitating the synthesis of essential biomolecules. The presence of ammonium can influence pH levels and osmotic balance within cells, thereby affecting cellular functions and enzyme activities.

Pharmacodynamics

Ammonium affects cellular metabolism by acting as a nitrogen donor in the synthesis of organic compounds. Its role in the nitrogen cycle and as a substrate in biochemical pathways allows for the maintenance of cellular functions, including energy production and cellular growth. Alterations in ammonium levels can influence various physiological processes, including neurotransmitter synthesis and energy metabolism.

Pharmacokinetics

Ammonium is readily absorbed and distributed in biological systems. It can be produced endogenously through amino acid metabolism or obtained from dietary sources. The excretion of ammonium primarily occurs through the kidneys, where it is converted to urea for elimination. Ammonium levels are regulated by various mechanisms, including the action of renal tubular cells that either secrete or reabsorb ammonium based on the body's needs.

Indications

• Cough associated with respiratory tract infections
• Acid-base disorders
• Edema management

Dosage

Children: Refer to the BNF for Children for appropriate paediatric dosing guidelines based on age and condition.

Adults: Refer to the BNF for specific adult dosing guidelines as they depend on the indication and clinical context.

Mechanism of action

Ammonium chloride increases acidity by raising hydrogen ion concentrations. It dissociates into ammonium and chloride ions; the ammonium is converted to urea in the liver, releasing hydrogen ions that lower pH. The chloride ions displace bicarbonate in extracellular fluid, leading to acidosis and increased renal excretion of electrolytes and water, resulting in fluid mobilization.

Pharmacodynamics

Ammonium chloride acts as a systemic acidifier, facilitating the excretion of chloride and sodium, while also increasing the acidity of body fluids. The conversion of ammonium to urea in the liver with the release of hydrogen ions contributes to a decrease in blood pH, affecting acid-base balance in the body.

Pharmacokinetics

Ammonium chloride is absorbed from the gastrointestinal tract and metabolized in the liver, where it is converted to urea. The dissociated ions impact renal function, leading to increased excretion of sodium, potassium, and water. The elimination half-life and specific metabolism details are not explicitly defined.

Adverse effects

• Nausea
• Vomiting
• Abdominal pain
• Diarrhea
• Dizziness
• Headache

Interactions

• Antacids may reduce the effectiveness of ammonium chloride
• Potassium-sparing diuretics may increase the risk of hyperkalemia

Precautions

• Use with caution in patients with renal impairment
• Monitor electrolyte levels during prolonged therapy
• Consider potential for acidosis in patients with liver disease

Pregnancy

Ammonium chloride should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus. Consult a healthcare provider for individualized advice.

Breast-feeding

Ammonium chloride is excreted in breast milk. Use caution and consult a healthcare provider if breastfeeding.

Storage

Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.

Formulations

• Oral solution
• Powder for oral solution

Dosage

Children: Refer to specific guidelines or clinical references for appropriate dosing.

Adults: Refer to specific guidelines or clinical references for appropriate dosing.

Mechanism of action

The mechanism of action of a compound can vary widely depending on its chemical structure and biological targets. Generally, compounds may act by interacting with specific receptors, enzymes, or cellular pathways to modulate physiological processes. For example, a compound may serve as an agonist or antagonist at receptor sites, inhibit enzyme activity, or alter ion channel function, leading to therapeutic effects.

Pharmacodynamics

Pharmacodynamics involves the study of how a compound affects the body. This includes the relationship between drug concentration and effect, as well as the time course of these effects. Compounds may exhibit dose-dependent responses, receptor binding affinities, and varying therapeutic indices. The efficacy and safety of a compound are critical in determining its clinical use.

Pharmacokinetics

Pharmacokinetics refers to the absorption, distribution, metabolism, and excretion (ADME) of a compound within the body. Factors such as bioavailability, half-life, volume of distribution, and clearance rates are essential in understanding how a compound behaves after administration. The pharmacokinetic profile can influence dosing regimens and the potential for drug interactions.

Indications

• Disinfection of medical and dental instruments
• Sterilization of surgical equipment
• Preservation of biological tissues
• Antimicrobial agent in laboratory settings

Dosage

Children: Refer to specific product guidelines for appropriate concentrations and exposure times, as dosing may vary based on the application.

Adults: Refer to specific product guidelines for appropriate concentrations and exposure times, as dosing may vary based on the application.

Mechanism of action

Glytaraldehyde exerts its antimicrobial effects through the formation of cross-links with proteins and nucleic acids. This cross-linking inhibits microbial growth and replication, leading to cell death. The dialdehyde structure allows glytaraldehyde to react with amino groups in proteins, disrupting cellular functions and integrity.

Pharmacodynamics

The pharmacodynamic profile of glytaraldehyde indicates its broad-spectrum antimicrobial activity, including bactericidal, virucidal, and fungicidal effects. Its potency is influenced by concentration, exposure time, and the nature of the microorganisms. Glytaraldehyde's effectiveness is enhanced in alkaline environments, where its reactivity increases.

Pharmacokinetics

Glytaraldehyde is not typically administered systemically; its primary use is topical as a disinfectant. When applied, it can penetrate biological tissues to some extent, but systemic absorption is minimal. The compound is rapidly inactivated by hydrolysis in aqueous solutions, leading to the formation of less toxic products. The exact pharmacokinetic parameters in humans are not well-defined due to its usage primarily as a disinfectant.

Adverse effects

• Skin irritation
• Eye irritation
• Respiratory issues
• Headache
• Nausea

Precautions

• Use with caution in individuals with respiratory conditions
• Avoid contact with skin and eyes
• Use in well-ventilated areas

Pregnancy

Safety during pregnancy has not been established; use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether glytaraldehyde is excreted in human milk; caution is advised.

Storage

Store in a cool, dry place away from light and moisture.

Indications

• Topical antiseptic
• Disinfectant for skin and surfaces
• Solvent for pharmaceutical preparations

Dosage

Children: For children, refer to specific guidelines on the use of isopropanol as a topical antiseptic; consult the BNF for Children for appropriate dosing and precautions.

Adults: For topical use, apply isopropanol to the affected area as needed. Ensure the skin is clean and dry before application.

Mechanism of action

Isopropanol exerts its antiseptic effects primarily by denaturing proteins and dissolving lipids, disrupting cellular membranes of bacteria, fungi, and viruses, leading to cell lysis and death. It is effective against a wide range of pathogens due to its ability to penetrate and disrupt microbial cell walls.

Pharmacodynamics

Isopropanol demonstrates a rapid onset of action when applied topically, providing effective antimicrobial activity. The concentration of isopropanol influences its efficacy; concentrations of 60-90% are most effective for disinfection. Its action is primarily bactericidal, with activity against both gram-positive and gram-negative bacteria, as well as certain viruses and fungi.

Pharmacokinetics

Isopropanol is primarily absorbed through the skin and mucous membranes, with peak plasma concentrations occurring shortly after exposure. It is rapidly metabolized in the liver, primarily to acetone, which is then further metabolized through various pathways. The elimination half-life is approximately 2-3 hours following systemic absorption, and isopropanol is excreted mainly via urine as metabolites.

Pregnancy

Isopropanol should be avoided during pregnancy due to potential risks to the developing fetus.

Breast-feeding

Isopropanol is not recommended during breastfeeding as it may be excreted in breast milk.

Storage

Store in a cool, dry place, away from heat and direct sunlight. Keep container tightly closed.

Indications

• Disinfection of surfaces
• Antiseptic for skin
• Cleansing agent in personal care products
• Industrial biocides

Dosage

Children: Refer to specific product guidelines for dosing, especially for topical antiseptics or disinfectants, as pediatric dosing should be carefully determined based on age and weight.

Adults: Refer to specific product guidelines for dosing, as it can vary based on formulation and intended use.

Mechanism of action

Quaternary ammonium compounds exert their antimicrobial effects by binding to the negatively charged components of microbial cell membranes. This interaction disrupts the membrane structure, resulting in increased permeability, leakage of cellular contents, and ultimately cell lysis. Additionally, quats can inactivate certain microbial enzymes and nucleic acids, further contributing to their antimicrobial activity.

Pharmacodynamics

Quaternary ammonium compounds exhibit broad-spectrum antimicrobial activity. Their efficacy varies depending on the specific compound and concentration used, with some being more effective against Gram-positive bacteria than Gram-negative bacteria. The bactericidal action is generally concentration-dependent, and the compounds can also have a residual effect on surfaces, providing ongoing antimicrobial protection.

Pharmacokinetics

The pharmacokinetics of quaternary ammonium compounds can vary widely among different members of this class. Generally, their systemic absorption is low when applied topically, leading to minimal systemic effects. They tend to be poorly absorbed through the gastrointestinal tract, and their action is primarily local. The elimination pathways may involve hepatic metabolism and renal excretion, but specific data can vary based on the individual compound.

Pregnancy

No well-controlled studies have been conducted in pregnant women. Use only if potential benefits justify potential risks to the fetus.

Breast-feeding

It is not known whether quaternary compounds are excreted in human milk. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Mechanism of action

Ammonium chloride increases acidity by increasing the amount of hydrogen ion concentrations. Ammonium chloride can be used as an expectorant due to its irritative action on the bronchial mucosa. This effect causes the production of respiratory tract fluid which in order facilitates the effective cough. The acid-forming properties of ammonium chloride result from dissociation of the salt to an ammonium cation and a chloride anion. In patients with normal hepatic function, the ammonium cation is converted to urea by the liver and a hydrogen cation is released which reacts with a bicarbonate ion to form water and carbon dioxide. The chloride anion combines with fixed bases in the extracellular fluid, thereby reducing the alkaline reserve of the body. The net result is the displacement of bicarbonate ions by chloride anions. The displacement of bicarbonate by chloride alters the bicarbonate:carbonic acid ratio if the body and acidosis results. The increased chloride concentration in the extracellular fluid produces an increased load to the renal tubules and appreciable amounts of chloride anions escape reabsorption. These anions are excreted along with cations and water. Sodium is the principal cation excreted; however, potassium excretion may also be increased to some degree. By increasing the excretion of both extracellular electrolytes and water, ammonium chloride causes a net loss of extracellular fluid and promotes the mobilization of edema fluid.

Pharmacodynamics

Systemic acidifier. In liver ammonium chloride is converted into urea with the liberation of hydrogen ions ( which lowers the pH) and chloride.